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In recent years, internet addiction disorder (IAD) has become more prevalent worldwide and the recognition of its devastating
impactontheusersandsocietyhasrapidlyincreased.However,theneurobiologicalmechanismofIADhasnotbeefullyexpressed.
The present study was designed to determine if the striatal dopamine transporter (DAT) levels measured by 99mTc-TRODAT-1
single photon emission computed tomography (SPECT) brain scans were altered in individuals with IAD. SPECT brain scans were
acquired on 5 male IAD subjects and 9 healthy age-matched controls. The volume (V) and weight (W) of bilateral corpus striatum
as well as the 99mTc-TRODAT-1 uptake ratio of corpus striatum/the whole brain (Ra) were calculated using mathematical models.
It was displayed that DAT expression level of striatum was signiﬁcantly decreased and the V, W, and Ra were greatly reduced in
the individuals with IAD compared to controls. Taken together, these results suggest that IAD may cause serious damages to the
brain and the neuroimaging ﬁndings further illustrate IAD is associated with dysfunctions in the dopaminergic brain systems. Our
ﬁndings also support the claim that IAD may share similar neurobiological abnormalities with other addictive disorders.
1.Introduction
The use of the internet has expanded incredibly across the
world over the last few years. The internet provides remote
access to others and abundant information in all areas
of interest. However, maladaptive use of the internet has
resultedinimpairmentoftheindividual’spsychologicalwell-
being, academic failure, and reduced work performance and,
especially leaded to internet addiction disorder (IAD) [1–
4]. IAD was ﬁrst raised in 1990s [5] and according to the
Beard’s deﬁnition of IAD, “an individual is addicted when an
individual’s psychological state, which includes both mental
andemotionalstates,aswellastheirscholastic,occupational,
and social interactions, is impaired by the overuse of the
medium.” [6]
In recent years, IAD has become more prevalent world-
wide; the recognition of its devastating impact on the
users and society has rapidly increased [7]. Importantly,
recent studies have found dysfunctions of IAD are similar
to other types of addictive disorders, such as substance
abuse disorders and pathological gambling [7–10]. People
experiencing IAD showed clinical features such as craving,
withdrawal and tolerance [7, 8], increased impulsiveness [9],
and impaired cognitive performance in tasks involving risky
decision-making [10].
As similar with the abnormalities in the dopaminergic
neural system in individuals with substance-related addic-
tion [11], the role of dopaminergic neural system in IAD
also has been elucidated in a few researches [12–14]. In a
recent study, people with IAD were found to have altered2 Journal of Biomedicine and Biotechnology
resting-state glucose metabolism in several brain regions
including the major dopamine projection areas such as the
striatum and orbitofrontal region [12]. Moreover, another
study found that adolescents with increased genetic poly-
morphisms in genes coding for the dopamine D2 receptor
and dopamine degradation enzyme were more susceptible
to excessive internet gaming compared with an age-matched
cohort of controls [14]. In a positron emission tomog-
raphy (PET) imaging study, reduced levels of dopamine
D2 receptor in subdivisions of the striatum including the
bilateral dorsal caudate and right putamen were found
in the individuals with IAD [13]. Taken together, these
ﬁndings suggest that IAD may also be partly due to impaired
dopaminergic neural systems similar to substance-related
addiction [15].
Dopamine transporter (DAT) is a protein situated in
the presynaptic terminal and striatal DAT is responsible for
the active dopamine reuptake into the presynaptic neuron
and plays a critical role in the regulation of striatal synaptic
dopamine levels [16–18]. Altered DAT concentration in
the striatum following chronic substance administration
has been reported previously [19–24]. However, whether
the abnormality of DAT also exists in IAD has not been
illustrated before.
In recent years, imaging of DAT has been used as an
important tool in clinical settings to display changes in the
brain structure of patients with substance-related addiction
[21–24]. In addition, the radiotracer 99mTc-TRODAT-1, a
technetium-99m (99mTc) labeled tropane derivative (tech-
netium,2-[[2-[[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo
[3, 2, 1]oct-2-yl]-methyl](2-mercaptoethyl)amino]ethyl]-
amino]ethanethiolato(3-)]-oxo-[1R-(exo-exo)]-), is regard-
ed as a safe and suitable imaging agent for monitoring DAT
status for human imaging studies [21, 25, 26]. In the present
study, we used single photon emission tomography (SPECT)
with the radiotracer 99mT c - T R O D A T - 1t oi n v e s t i g a t es t r i a t a l
DAT density to identify potential presynaptic abnormalities
in IAD subjects compared to age-matched healthy controls.
This study aims to test the hypothesis that the altered
availability of DAT is associated with the pathogenesis of
IAD.
2.MaterialsandMethods
2.1. Diagnosed Criteria of IAD. IAD was assessed using
Young’s Internet Addiction Diagnostic Questionnaire
(IADDQ) [4] and Goldberg’s Internet addictive Disorder
Diagnostic Criteria (IADDC) [27]. All of the questions of
IADDQ and IADDC were translated into Chinese. To be
eligible, participants in the IAD group were asserted that ﬁve
or more “yes” responses to the eight questions of IADDQ
and to satisfy three or more of IADDC (i.e., tolerance,
withdrawal, craving and unplanned use, failure to reduce
use, excessive use, sacriﬁcing social activities to use, and
physical and psychological problems associated with use).
2.2. Subjects. Five men (mean ± SD, 20.40 ± 2.30 years old)
with IAD were randomly selected from the patients seeking
treatment at the Peking University Shenzhen Hospital.
The IAD subjects used the internet almost everyday, and
spend more than 8 hours (mean±SD, 10.20 ± 1.48 hours)
everyday in front of the monitor, mostly for chatting with
cyber friends, playing online games, and watching online
pornographies or adult movies. These subjects were initially
familiar with internet mostly at the early stage of their
adolescence (mean age ± SD, 12.80±1.92 years old) and had
the indications of IAD for more than 6 years (mean ± SD,
7.60 ±1.52 years).
Nine age-matched controls (mean ± SD, 20.44 ± 1.13
years old) recruited through advertisement participated in
this study. No statistical diﬀerence was found for the ages
of the participants between the two groups (P = 0.96). The
participants in the control group used Internet occasionally
or frequently but spent no more than 5 hours a day on the
line (mean ± SD, 3.81 ± 0.76 hours) and did not satisfy the
diagnosed criteria of IAD [4, 27].
All the recruited participants were native Chinese speak-
ers, never used illegal substances (sometimes, a few of the
participants smoked or drink alcohol, but none of them
meet the diagnosis criteria of substance-related disorders
[28]), had no history of signiﬁcant medical, neurological
or psychiatric diseases, and were right-handed. All the
participants gave written informed consent before participa-
tion after the nature of the procedure was fully explained,
including possible risks and side eﬀects. All procedures for
this study were approved by the ethics committee of the
Peking University Shenzhen Hospital.
2.3. Imaging. TRODAT-1 ligand (liquid) was supplied by the
Department of Chemistry, Beijing Normal University (Bei-
jing, China). The radiotracer 99mTc-TRODAT-1, 740MBq
(20mCi) with purity >90% was synthesized as described
previously [25]. And SPECT studies with 99mTc-TRODAT-
1 were carried out using a Siemens DIACAM/E.CAM/ICON
double detector SPECT with lower-energy all-purpose colli-
mator (Siemens, Erlangen, Germany). The imaging method
was performed as described previously [25, 29]. Sub-
jects were injected intravenously with 740MBq (20mCi)
of 99mTc-TRODAT-1. Imaging was performed 2.5h after
the administration of 99mTc-TRODAT-1. The acquisition
parameters included 64 views over 18s per view and a 128 ×
128 matrix over 360◦ with a rotation in 5.6◦ increments.
Transverse reconstruction backprojection was applied to the
raw data. A Butterworth ﬁlter was then applied with an
order of 15 and a cutoﬀ of 0.33 Nyquist frequency. Photon
attenuation correction was performed using Chang’s ﬁrst
order correction method using an attenuation coeﬃcient of
0.15cm−1 [30]. The transverse image thickness was 2.7mm
(1 pixel). All images were processed and reconstructed using
the same procedure.
2.4. Image Analysis. Image analysis was done using the
region ratio software of the E-Cam. Regions of interest
(ROIs) were drawn on 12 transverse images, the pixels were
extracted and counts of whole brain and bilateral corpus
striatum were carried out. The volume (V) and weight
(W) of bilateral corpus striatum as well as the ratio ofJournal of Biomedicine and Biotechnology 3
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Figure 1: (a,b) representative 99mTc-TRODAT-1 SPECT images of an IAD subject in comparison with an age-matched healthy control
((a) a 20-year-old male IAD subject; (b) a 20-year-old male healthy control). Left hemisphere is on right side of image. The IAD subject
demonstrates a signiﬁcant decrease in binding of 99mTc-TRODAT-1 to the DAT in the striatum and the bilateral corpus striatum is much
smaller and more irregular than that in the control.
corpus striatum/the whole brain (Ra) was calculated using
the mathematical models as described in the previous paper
[21, 31].
2.5. Data Analysis. Data in the present paper are presented
as means ± standard (mean ± SD). Statistical Program for
the Social Sciences for Windows, version 11 (SPSS 13.0, SPSS
Inc, Chicago, USA) was used to analyze the data. Diﬀerences
between the groups were assessed by Student’s t-test. For all
of the tests conducted, the criterion for signiﬁcance was set
at P<0.05.
3. Results
The DAT images of the bilateral corpus striatum in the
control group showed a panda-eye shape and DATs were
distributed uniformly and symmetrically in the corpus
striatum. The bilateral corpus striatum was situated on
8–12 layers, as shown in Figure 1(b). However, the DAT
images of the IAD subjects displayed diﬀerent levels of
abnormity, in which the corpus stratums were much smaller
and showed diﬀerent shapes, dumbbell, thin strip, lunate
shape, or sporadic spot (Figure 1(a)).
AsshowninFigure 1andTable 1,DATexpressionlevelof
striatum was signiﬁcantly decreased in IAD subjects. Brieﬂy,
in comparison with the controls, there were signiﬁcantly
lower values of V (cm3), W (g) and Ra of corpus striatum in
the IAD group, suggesting that decreased 99mTc-TRODAT-
1b o u n dt oD A To ri m p a i r m e n ta sw e l la sd y s f u n c t i o no f
corpusstriatumoccurred.Nostatisticaldiﬀerencewasfound
as comparing V or W of the bilateral corpus striatum (left
side and right side) either in the IAD group (P = 0.67 and
P = 0.68 resp.) or in the health control group (P = 0.10 and
P = 0.11 resp.).
4. Discussion
IAD resulted in impaired individual psychological well-
being, academic failure, and reduced work performance,
especially among adolescents [1–4]. However, there is
currently no standardized treatment targeted for IAD. To
develop eﬀective methods for intervention and treatment of
IAD, it will ﬁrst require establishing a clear understanding of
the underlying neurobiological mechanisms. In the present
study, we assessed the DAT expression level in IAD subjects
and healthy controls using 99mTc-TRODAT-1 SPECT. We
found that DAT expression level of striatum was signiﬁcantly4 Journal of Biomedicine and Biotechnology
Table 1: Comparison of corpus striatum V (cm3), W (g), and Ra between IAD subjects and the controls.
Volume of corpus striatumV (cm3) Weight of corpus striatumW (g)
Ratio of corpus
striatum/whole
brain
VL (left side) VR (right side) WL (left side) WR (right side) Ra (%)
Controls (n = 9) 16.69 ±1.63 18.17 ±2.00 17.53 ±1.71 19.08 ±2.10 7.93 ±0.75
IAD subjects (n = 5) 11.72 ±3.13
∗ 12.51 ±2.53
∗∗ 12.30 ±3.28
∗ 13.14 ±2.10
∗∗ 5.38 ±0.77
∗∗
Values are expressed as mean ± SD with ∗P<0.05 and ∗∗P<0.01.
decreased and the values of V, W, and Ra of the corpus
striatum in IAD subjects were greatly reduced. The imaging
results provided the direct-viewing proof of altered availabil-
ity of DAT in brain of people with IAD.
DATs play a critical role in the regulation of striatal
synaptic dopamine levels [16–18]a n dh a v eb e e nu s e da s
markers of the dopamine terminals [32]. A reduced number
of cell membrane DATs may possibly reﬂect pronounced
striatal dopamine terminal loss or the brain dopaminergic
function impairment which has been found in substance-
related addiction [21–23]. PET imaging studies have found
increased release of dopamine in the striatum during the
video game [33]. Patients with pathological gambling also
demonstrated high level of dopamine in the ventral stria-
tum during gambling [34]. Because increased extracellular
dopamine in the striatum is associated with subjective
descriptors of reward (high, euphoria) [11, 35], individuals
with IAD may also experience euphoria as the extracellular
dopamine in the striatum increases. However, long-time
and high concentrations of dopamine have been shown
to cause a selective lesion of dopamine terminals [32, 36]
and decreased size of dopaminergic cell bodies [20]. Taken
together, the reduced DATs found in our study may indicate
the neuropathologic damage to the dopaminergic neural
system caused by IAD.
According to our knowledge, this is the ﬁrst imaging
study to examine the abnormality of DAT in the brain
of IAD subjects. Furthermore, the imaging results of the
present study provide the objective proofs that long-term
maladaptive use internet might cause serious problems.
However, for complete interpretation of the results of the
present study, some limitations should be noted. Firstly, the
small sample size of our study may limit the generalizability
of our results. Those positive associations in our study
might have been due to chance or a stratiﬁcation eﬀect in
the sample collection, and further studies in independent
samples or a larger population are required. Secondly, the
IAD subjects in the present study reported diﬀerent desired
activities when they are sitting in front of the monitor
(including chatting with cyber friends, playing online games,
watching online pornographies or adult movies, etc.). Our
study can not determine whether the diﬀerent types of
Internet behaviors may cause diﬀerent brain DAT changes.
Therefore, the present study can only be recognized as
exploratory and primary, and more research work should be
done before we get the most deﬁnitive conclusion.
5. Conclusion
The results from this study provide evidence that IAD may
induce signiﬁcant DAT losses in the brain and these ﬁndings
suggest that IAD is associated with dysfunctions in the
dopaminergicbrainsystemsandareconsistentwithprevious
reports in various types of addictions either with or without
substances [21–23, 37]. Our ﬁndings support the claim that
IAD may share similar neurobiological abnormalities with
other addictive disorders [15].
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